The Sema Question
What is the consultation offering?
33 brand reviews follow the questions a care description leaves open: who assesses, what is being considered and how the next conversation happens.
Explicit microdosing offers, broader weight-care programs and institutions describe different services. Inclusion here does not confirm a microdosing prescription or select treatment for you.
33 brand reviews.
The consultation question
Review the advertised goals and assessment process, with exact-medicine, follow-up and offer uncertainties kept in view.
The documented service
Advertised compounded GLP-1 microdosing service with clinical review; the selected medicine and care arrangements require individual confirmation.
The consultation question
Examine what AgelessRx says about intake, provider review and ongoing support without assuming that a broad wellness goal establishes an indication.
The documented service
Advertised semaglutide microdosing program with remote assessment; product identity, prescribing roles and follow-up need separate confirmation.
The consultation question
One Medical describes weight assessment in the context of health history and ongoing care; quick app access and scheduled clinical visits are different services.
The documented service
Primary-care weight assessment and possible medication management; scheduled clinical visits differ from app access, and seniors coverage is plan- and location-specific.
The consultation question
Amble describes clinician review and state-dependent encounter formats, while its terms explain limits of remote assessment and messaging.
The documented service
Online weight-care assessment with state-dependent encounter formats; independent providers assess clinical suitability, and messages are not real-time emergency care.
The consultation question
Read the published video-visit and coordination arrangements while keeping employer criteria and product-policy limits in context.
The documented service
Broader metabolic care with video clinical assessment and an explicit no-compounded-GLP-1 policy; no microdose offer verified.
The consultation question
Cleveland describes history-taking, examination and ongoing medical weight care. The useful questions concern how those findings become an explained plan.
The documented service
Medical weight-management assessment and follow-up; no confirmed microdosing pathway or personally selected medicine.
The consultation question
DrHouse describes medical assessment that may lead to a prescription, laboratory work, referral or other guidance; a visit does not guarantee the requested medicine.
The documented service
Virtual physician assessment for possible GLP-1 care; a completed visit can lead to guidance, testing or referral without the requested prescription.
The consultation question
Duke describes medical evaluation alongside nutrition and behavioral care. The important distinction is between collecting information and making an explained clinical decision.
The documented service
Durham clinical weight-management assessment with nutrition and behavioral support; no verified exact microdose prescription or individual handoff.
The consultation question
Eden’s program article describes history, possible laboratory work and follow-up, while its terms preserve independent clinical decisions.
The documented service
Online consultation through independent providers, with published history and follow-up descriptions; selected testing, treatment and outside coordination are individual decisions.
The consultation question
Examine the stated record-sharing and physical-examination limits behind Form’s clinician and dietitian appointments.
The documented service
Broader clinician-and-dietitian weight care with PCP and record-sharing requirements; no compounded microdose service established.
The consultation question
Examine the clinician’s role when a compounded microdosing offer presents broad metabolic and wellness aims.
The documented service
Explicit compounded-semaglutide microdosing within a broader clinical program; personal assessment and exact product remain conditional.
The consultation question
Fridays separates its website assessment from a doctor-patient relationship and describes clinical care through distinct practices.
The documented service
Advertised compounded microdose care through separate clinical practices; preliminary assessment does not create a doctor-patient relationship and exact product labels need clarification.
The consultation question
Read the independent medical-group role, encounter limits and ongoing support around an explicit compounded microdosing offer.
The documented service
Explicit compounded-semaglutide microdosing with conditional medical-group assessment, location requirements and telehealth limits.
The consultation question
Read Hims’ history review, variable visit format and continuing support as distinct parts of a clinical relationship.
The documented service
Broader weight-care assessment with state-dependent encounter arrangements; no compounded microdose program verified.
The consultation question
Ivim describes provider assessment, coaching and administrative support, with specific limits on medication access and the end of a clinical relationship.
The documented service
Online GLP-1 assessment with provider, coaching and patient-experience roles; medication access is conditional and transition support has stated limits.
The consultation question
Hopkins describes evaluation, continuing physician care and additional support. The indexed record identifies roles without verifying a personal encounter or current access.
The documented service
Physician-led weight care documented through an indexed official-page record; current individual access, product and care outcomes remain unverified.
The consultation question
Examine the stated provider and laboratory sequence, separate support roles and government-coverage exclusion.
The documented service
Broader clinical weight care with laboratory review and a government-coverage exclusion; no microdose-specific program verified.
The consultation question
Likeness Rx offers online access to compounded semaglutide and tirzepatide. Its public page lists semaglutide from $79/month; tirzepatide from $129/month.
The documented service
Compounded semaglutide and tirzepatide
The consultation question
Mayo’s Jacksonville appointment record describes history, goals and possible next steps. It leaves the individual recommendation to the clinical encounter.
The documented service
Jacksonville bariatric-center consultation and qualified Mayo access information; no confirmed personal medicine or microdosing service.
The consultation question
Mochi describes video assessment, several support roles and access to records. Those are different parts of continuity.
The documented service
Online weight-management consultations with published intake, support-role and record-access information; individual treatment and outside coordination remain unverified.
The consultation question
Read Noom’s advertised clinical process alongside its broader program features, without treating app access or a requested medicine as a clinical decision.
The documented service
Advertised microdosing care with behavioral support; eligibility, medicine selection and follow-up remain conditional on assessment.
The consultation question
Northwestern describes adult and regional services with different assessment roles. Its consultation FAQ is useful only with its outdated medicine examples kept in view.
The documented service
Adult Lifestyle Medicine and separate Western Suburbs clinical assessment services; no verified individual prescription or uniform institution-wide workflow.
The consultation question
NYU describes a clinical weight program and continuing supervision of medication care. A named option still needs an individual explanation and product record.
The documented service
Clinical weight assessment and supervised medication care; exact personal product, access and communication arrangements are unconfirmed.
The consultation question
Read the assessment, laboratory and monitoring descriptions while keeping the service’s exclusions and outside-care limits clear.
The documented service
Broader physician-led weight management with conditional medicine evaluation; no confirmed compounded microdose program.
The consultation question
RemedyMeds advertises clinician contact while its terms distinguish independent medical groups from nonclinical platform staff.
The documented service
Advertised microdose program and compounded GLP-1 care through independent clinical entities; company support roles are nonclinical and individual care remains unverified.
The consultation question
Consider who reviews health information, identifies the medicine and follows concerns after the insurance and pharmacy steps.
The documented service
Broader multi-medicine weight care with affiliated provider assessment; no microdose-specific service verified.
The consultation question
Success by Sesame describes a dedicated provider and ongoing contact, with important beneficiary and laboratory-inclusion limits.
The documented service
Online weight-management consultations and follow-up with a dedicated provider; federal-program beneficiary exclusions and state-specific laboratory-inclusion limits apply.
The consultation question
Stanford documents evaluation, conditional medication care and coordination for patients referred by their primary-care clinician. That condition should remain visible.
The documented service
Multidisciplinary weight assessment and conditional GLP-1 care; PCP coordination is described for referred patients, not verified for every encounter.
The consultation question
A current-source review of SuperHealthy Rx semaglutide microdosing: a first consultation that leaves room for questions, billing questions and evidence limits.
The documented service
Read the dated review for the documented offering and its limitations.
The consultation question
UCLA’s cited program describes medical and nutrition assessment. Medication-history review is relevant information, not confirmation of GLP-1 prescribing.
The documented service
Clinical nutrition and medical weight-management assessment; no confirmed GLP-1 prescribing in the cited program records.
The consultation question
Distinguish the affiliated medical group, dietitian visits, coaching and app features before treating them as one consultation.
The documented service
Broader Med+ care through an affiliated medical group; no compounded microdosing service established.
The consultation question
What this review can establish today, what the October record showed, and which product and payment questions still need an answer.
The documented service
Specific microdose product details were unavailable at our November 8 recheck. Read the dated findings and the questions still unresolved.
The consultation question
Yale describes nonsurgical and multidisciplinary weight care. A goal, a professional referral and a procedure plan remain distinct clinical questions.
The documented service
Nonsurgical metabolic care and a broader multidisciplinary weight center; historical access wording and individual treatment limits remain explicit.
Read the consultation comparison →